Drugs & Aging

, Volume 22, Issue 9, pp 767–777 | Cite as

Adverse Drug Reactions in an Elderly Hospitalised Population

Inappropriate Prescription is a Leading Cause
  • Maria Cristina G. Passarelli
  • Wilson Jacob-Filho
  • Albert Figueras
Original Research Article



Adverse drug reactions (ADRs) represent a major public health problem in the aged. In order to better evaluate this problem in Brazil, this study was designed to assess the prevalence of ADRs in an elderly hospitalised population, identify the most common ADRs and the principal medications involved, evaluate the appropriateness of use of these drugs in elderly people and determine the risk factors implicated in the appearance of such ADRs.


The study population was comprised of 186 elderly patients (≤60 years of age) admitted to the internal medicine service of a teaching hospital. The patients were assessed by a single observer using an intensive drug surveillance method to identify and report ADRs. The degree of probability for each adverse reaction was determined using the Naranjo algorithm.


The mean (± SD) age of the patients studied was 73.6 ± 9.1 years. Up to 115 patients (61.8%) of the study population presented at least one ADR. A total of 199 ADRs were found, at an average of 1.7 per patient. The ADRs appeared during hospitalisation in 46.2% of the study population, were present at the time of the admission but did not cause hospitalisation in 17.2% of patients, and were the cause of admission in 11.3% of patients. The most frequent ADR that caused hospitalisation was digitalis toxicity (22.7% of such ADRs). Hypokalaemia as a result of diuretics was the most prevalent ADR both during hospitalisation (11.8%) and at the time of admission without being the cause (12.1%). Captopril was the most frequently prescribed drug (138 prescriptions), and led to an ADR in 18.1% of patients who received the drug. Almost a quarter of the patients presenting an ADR were prescribed drugs considered inappropriate for the elderly. By means of a multiple logistic regression model, the following were considered to be significant risk factors for the appearance of ADRs: number of diagnoses (odds ratio [OR] 1.40; 95% CI 1.06, 1.86), number of drugs (OR 1.07; 95% CI 1.01, 1.13) and use of drug that is inappropriate for the elderly (OR 2.32; 95% CI 1.17, 4.59).


The main contribution of the present study was identification of use of drugs that are considered inappropriate for elderly populations as a major risk factor for presenting an ADR. This finding is useful for continuous education programmes, therapeutic committees and policy makers, because adverse effects complicate the course of diseases in aged patients, cause hospitalisation and/or require the prescription of additional drugs. In addition to contributing to a reduction in healthcare costs, continuous efforts to promote rational drug use could also benefit elderly patients by preventing some avoidable drug toxicity.


A significant prevalence of ADRs was found among hospitalised elderly people. The risk factors associated with ADRs in this population included use of drugs considered to be inappropriate for that population, number of previous diagnoses and number of administered drugs. More appropriate drug prescription could avoid part of this burden of disease by minimising preventable ADRs.


  1. 1.
    Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51(18): 2268–72PubMedGoogle Scholar
  2. 2.
    Melmon KL. Preventable drug reactions: causes and cures. N Engl J Med 1971; 284(24): 1361–8PubMedCrossRefGoogle Scholar
  3. 3.
    Lucas LM, Colley CA. Recognizing and reporting adverse drug reactions. West J Med 1991; 156: 172–5Google Scholar
  4. 4.
    Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reactions monitoring: cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf 1997; 6Suppl. 3: S71–7PubMedCrossRefGoogle Scholar
  5. 5.
    Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15–9PubMedCrossRefGoogle Scholar
  6. 6.
    Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50(12): 1962–8PubMedCrossRefGoogle Scholar
  7. 7.
    World Health Organization. Adverse drug reactions in the elderly. In: Caird FI, editor. Drugs for the elderly. Copenhagen: WHO, 1989: 23–8Google Scholar
  8. 8.
    World Health Organization. The uses of epidemiology in the study of the elderly. Report of a WHO scientific group on the epidemiology of aging. Geneva: WHO, 1984: 1–84. Technical Report Series no: 706Google Scholar
  9. 9.
    Katz S. Assessing self-maintenance: activities of daily living, mobility instrumental activities of daily living. J Am Geriatr Soc 1983; 31(12): 721–7PubMedGoogle Scholar
  10. 10.
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–98PubMedCrossRefGoogle Scholar
  11. 11.
    Herrera Jr E, Caramelli P, Silveira ASB, et al. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16(2): 103–8PubMedCrossRefGoogle Scholar
  12. 12.
    Laporte JR. Farmacovigilancia en el hospital. In: Laporte JR, Tognoni G, editors. Principios de Epidemiologia del Medicamento. Segunda edición. Barcelona: Masson, 1993: 219–31Google Scholar
  13. 13.
    Dukes MNG, Aronson JK, editors. Meyler’s side effects of drugs. 14th ed. New York: Elsevier Science, 2000Google Scholar
  14. 14.
    Drugdex drug evaluations. Micromedex healthcare series (database on CDRom). Syracuse (NY): Thomson Micromedex: vols. 113 (2002 Jul–Sep), 114 (2002 Oct–Dec), 115 (2003 Jan–Mar), 116 (2003 Apr–Jun), 117 (2003 July–Sep), 118 (2003 Oct–Dec), 119 (2004 Jan–Mar), 120 (2004 Apr–Jun)Google Scholar
  15. 15.
    Davies DM, Ferner RE, de Glanville H, editors. Davies’ textbook of adverse drug reactions. 5th ed. London: Chapman and Hall Medical, 1998Google Scholar
  16. 16.
    Bénichou C, editor. Adverse drug reactions: a practical guide to diagnosis and management. Chichester: John Wiley and Sons, 1994Google Scholar
  17. 17.
    Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45PubMedCrossRefGoogle Scholar
  18. 18.
    Meyboom RHB, Egberts ACG, Gribnau FWJ, et al. Pharmacovigilance in perspective. Drug Saf 1999; 21: 429–47PubMedCrossRefGoogle Scholar
  19. 19.
    Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis and management. Lancet 2000; 356(9237): 1255–9PubMedCrossRefGoogle Scholar
  20. 20.
    Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000; 22(6): 415–23PubMedCrossRefGoogle Scholar
  21. 21.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRefGoogle Scholar
  22. 22.
    O’Conner PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338(9): 592–602CrossRefGoogle Scholar
  23. 23.
    Beijer HJM, de Blaey CJ. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46–54PubMedCrossRefGoogle Scholar
  24. 24.
    Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39(11): 1093–9PubMedGoogle Scholar
  25. 25.
    van Kraaij DJW, Haagsma CJ, Go IH, et al. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 1994; 44(5): 166–73PubMedCrossRefGoogle Scholar
  26. 26.
    González-Martin G, Yáñez LC, Valenzuela EA. Reacciones adversas a medicamentos en pacientes geriátricos hospitalizados. Estudio prospectivo. Rev Méd Chile 1997; 125(10): 1129–36PubMedGoogle Scholar
  27. 27.
    von Renteln-Kruse W. Does frailty predispose to adverse drug reactions in older patients? [letter]. Age Ageing 2000; 29(5): 461–2CrossRefGoogle Scholar
  28. 28.
    Leach S, Roy SS. Adverse drug reactions: an investigation on an acute geriatric ward. Age Ageing 1986; 15(4): 241–6PubMedCrossRefGoogle Scholar
  29. 29.
    Somers A, Petrovic M, Robays H, et al. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003; 58(10): 707–14PubMedGoogle Scholar
  30. 30.
    May FE, Fuller S, Stewart RB. Drug use and adverse drug reactions prior to and during hospitalization. J Am Pharm Assoc 1977; 17(9): 560–8PubMedGoogle Scholar
  31. 31.
    Klein U, Klein M, Sturm H, et al. The frequency of adverse drug reactions as dependent upon age, sex and duration of hospitalization. Int J Clin Pharmacol 1976; 13(3): 187–95Google Scholar
  32. 32.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5PubMedCrossRefGoogle Scholar
  33. 33.
    Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266(20): 2847–51PubMedCrossRefGoogle Scholar
  34. 34.
    Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2003; 57: 121–6CrossRefGoogle Scholar
  35. 35.
    Denham MJ. Adverse drug reactions. Br Med Bull 1990; 46(1): 53–62PubMedGoogle Scholar
  36. 36.
    Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14(2): 141–52PubMedCrossRefGoogle Scholar
  37. 37.
    Rawlins MD, Thomas SHL. Mechanisms of adverse drug reactions. In: Davies DM, Ferner RE, de Glanville H, editors. Davies’s textbook of adverse drug reactions. 5th ed. London: Chapman and Hall Medical, 1998Google Scholar
  38. 38.
    Nolan L, O’Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36(2): 142–9PubMedGoogle Scholar
  39. 39.
    Hutchinson TA, Flegel KM, Kramer MS, et al. Frequency, severity and risk factors for adverse drug reactions in adult-outpatients: a prospective study. J Chronic Dis 1986; 39(7): 533–42PubMedCrossRefGoogle Scholar
  40. 40.
    Schneider JK, Mion LC, Frengley JD. Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm 1992; 49(1): 90–6PubMedGoogle Scholar
  41. 41.
    Veehof LJG, Stewart RE, Meyboom B, et al. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55(7): 533–6PubMedCrossRefGoogle Scholar
  42. 42.
    Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36(12): 1092–8PubMedGoogle Scholar
  43. 43.
    Naranjo CA, Ruiz I, Busto U, et al. Un estúdio prospectivo de farmacovigilancia en el hospital clinico de la Universidad de Chile. Rev Méd Chile 1978; 106(3): 176–81PubMedGoogle Scholar
  44. 44.
    Mjörndal T, Boman MD, Hägg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 2002; 11(1): 65–72PubMedCrossRefGoogle Scholar
  45. 45.
    Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31(4): 199–205PubMedCrossRefGoogle Scholar
  46. 46.
    Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 56(2): 181–6PubMedCrossRefGoogle Scholar
  47. 47.
    Roughead EE, Gilbert AL, Primrose JG, et al. Drug-related hospital admissions: a review of Australian studies published 1988–1996. Med J Aust 1998; 168(8): 405–8PubMedGoogle Scholar
  48. 48.
    Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm 2003; 60(3): 253–9PubMedGoogle Scholar
  49. 49.
    Levy M, Lipshitz M, Eliakim M. Hospital admissions due to adverse drug reactions. Am J Med Sci 1979; 277(1): 49–56PubMedCrossRefGoogle Scholar
  50. 50.
    Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48(3): 161–6PubMedGoogle Scholar
  51. 51.
    Mannesse CK, Derkx FH, Ridder MAJ, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29(1): 35–9PubMedCrossRefGoogle Scholar
  52. 52.
    Björkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36(1): 1675–81PubMedCrossRefGoogle Scholar
  53. 53.
    Seymour R, Routledge PA. Important drug-drug interactions in the elderly. Drugs Aging 1998; 12(6): 485–94PubMedCrossRefGoogle Scholar
  54. 54.
    Köhler GI, Bode-Böger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharm Ther 2000; 38(11): 504–13Google Scholar
  55. 55.
    Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21(4): 294–300PubMedCrossRefGoogle Scholar
  56. 56.
    McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156(3): 385–91PubMedGoogle Scholar
  57. 57.
    Kalache A, Veras RP, Ramos LR. The ageing of the world’s population: a new challenge. Rev Saude Publica 1987; 21: 200–10PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Maria Cristina G. Passarelli
    • 1
  • Wilson Jacob-Filho
    • 1
  • Albert Figueras
    • 2
  1. 1.School of MedicineUniversity of São PauloSão PauloBrazil
  2. 2.Fundació Institut Català de Farmacologia and Universitat Autònoma de BarcelonaBarcelonaSpain

Personalised recommendations